Latest news with #AIMI
New Straits Times
7 days ago
- Health
- New Straits Times
MOHE unveils virtual counsellor 'AIMI' to support students' mental health
LUMUT: A virtual counsellor capable of interacting with individuals facing mental health challenges, known as AI Menyantuni Insan (AIMI), has been introduced for the first time by the Ministry of Higher Education (MOHE) in conjunction with the Perak Madani Rakyat Programme (PMR) 2025 held at Lumut Waterfront here. Although still in the prototype phase and based on artificial intelligence (AI), AIMI is capable of being a listener and a supportive companion in addressing mental health issues, particularly among students in higher learning institutions. Higher Education Director-General Prof Datuk Dr Azlinda Azman said the prototype phase of the AI application is a new and innovative approach to tackling stress, anxiety and depression among students in tertiary education. "We know that in Malaysia there are three million people suffering from mental health issues, but we only have 18,000 certified counsellors. "That's why this application was developed, to help those with mental health problems, especially students in higher education institutions. "At the very least, when someone is experiencing stress, anxiety or depression, AIMI can act as a frontliner for them to express their emotions by communicating and interacting through the AI developed," she said here today. Earlier, Prime Minister Datuk Seri Anwar Ibrahim, during a visit to the MOHE booth, had the opportunity to receive a briefing on the progress of the AIMI prototype after officiating the Closing Ceremony of Perak PMR 2025. The virtual application 'AIMI', portrayed as a 'woman' with the ability to speak in both Malay and English, is one of the efforts in AI development following the launch of the AI Faculty at Universiti Teknologi Malaysia last year. Azlinda said that through the AI Faculty, MOHE has also established the Malaysia AI Consortium involving both public and private universities in the country, with each institution having its own specific area of focus. At Perak PMR 2025, MOHE showcased the AIMI prototype to the public for testing and to gather feedback on any needs or features to be improved before its expected launch at the Festival of Ideas in Putrajaya this November. Azlinda said the creation of the virtual application involved the collaboration of various experts, including those in creative design, medicine, psychology and strategic planning. "The beauty of our AI counsellor prototype is that it has been developed by experts among local lecturers who can provide guidance shaped by the values of our own society. "This AI was developed by MOHE through the Department of Higher Education and public universities, with Universiti Teknologi Mara (UiTM) Perak Branch spearheading the mental health AI counsellor prototype project, in collaboration with other local universities such as Universiti Teknologi Malaysia and Universiti Zainal Abidin," she said.
The Sun
15-06-2025
- Health
- The Sun
MOHE unveils virtual counsellor ‘AIMI' to support students' mental health
LUMUT: A virtual counsellor capable of interacting with individuals facing mental health challenges, known as AI Menyantuni Insan (AIMI), has been introduced for the first time by the Ministry of Higher Education (MOHE) in conjunction with the Perak MADANI Rakyat Programme (PMR) 2025 held at Lumut Waterfront here. Although still in the prototype phase and based on artificial intelligence (AI), AIMI is capable of being a listener and a supportive companion in addressing mental health issues, particularly among students in higher learning institutions. Higher Education Director-General Prof Datuk Dr Azlinda Azman said the prototype phase of the AI application is a new and innovative approach to tackling stress, anxiety and depression among students in tertiary education. 'We know that in Malaysia there are three million people suffering from mental health issues, but we only have 18,000 certified counsellors. That's why this application was developed — to help those with mental health problems, especially students in higher education institutions. 'At the very least, when someone is experiencing stress, anxiety or depression, AIMI can act as a frontliner for them to express their emotions by communicating and interacting through the AI developed,' she said here today. Earlier, Prime Minister Datuk Seri Anwar Ibrahim, during a visit to the MOHE booth, had the opportunity to receive a briefing on the progress of the AIMI prototype after officiating the Closing Ceremony of Perak PMR 2025. The virtual application 'AIMI', portrayed as a 'woman' with the ability to speak in both Malay and English, is one of the efforts in AI development following the launch of the AI Faculty at Universiti Teknologi Malaysia last year. Azlinda said that through the AI Faculty, MOHE has also established the Malaysia AI Consortium involving both public and private universities in the country, with each institution having its own specific area of focus. At Perak PMR 2025, MOHE showcased the AIMI prototype to the public for testing and to gather feedback on any needs or features to be improved before its expected launch at the Festival of Ideas in Putrajaya this November. Azlinda noted that the creation of the virtual application involved the collaboration of various experts, including those in creative design, medicine, psychology and strategic planning. 'The beauty of our AI counsellor prototype is that it has been developed by experts among local lecturers who can provide guidance shaped by the values of our own society. 'This AI was developed by MOHE through the Department of Higher Education and public universities, with Universiti Teknologi MARA (UiTM) Perak Branch spearheading the mental health AI counsellor prototype project, in collaboration with other local universities such as Universiti Teknologi Malaysia and Universiti Zainal Abidin,' she said.
The Sun
15-06-2025
- Health
- The Sun
MOHE Unveils AIMI AI Virtual Counsellor for Mental Health
LUMUT: A virtual counsellor capable of interacting with individuals facing mental health challenges, known as AI Menyantuni Insan (AIMI), has been introduced for the first time by the Ministry of Higher Education (MOHE) in conjunction with the Perak MADANI Rakyat Programme (PMR) 2025 held at Lumut Waterfront here. Although still in the prototype phase and based on artificial intelligence (AI), AIMI is capable of being a listener and a supportive companion in addressing mental health issues, particularly among students in higher learning institutions. Higher Education Director-General Prof Datuk Dr Azlinda Azman said the prototype phase of the AI application is a new and innovative approach to tackling stress, anxiety and depression among students in tertiary education. 'We know that in Malaysia there are three million people suffering from mental health issues, but we only have 18,000 certified counsellors. That's why this application was developed — to help those with mental health problems, especially students in higher education institutions. 'At the very least, when someone is experiencing stress, anxiety or depression, AIMI can act as a frontliner for them to express their emotions by communicating and interacting through the AI developed,' she said here today. Earlier, Prime Minister Datuk Seri Anwar Ibrahim, during a visit to the MOHE booth, had the opportunity to receive a briefing on the progress of the AIMI prototype after officiating the Closing Ceremony of Perak PMR 2025. The virtual application 'AIMI', portrayed as a 'woman' with the ability to speak in both Malay and English, is one of the efforts in AI development following the launch of the AI Faculty at Universiti Teknologi Malaysia last year. Azlinda said that through the AI Faculty, MOHE has also established the Malaysia AI Consortium involving both public and private universities in the country, with each institution having its own specific area of focus. At Perak PMR 2025, MOHE showcased the AIMI prototype to the public for testing and to gather feedback on any needs or features to be improved before its expected launch at the Festival of Ideas in Putrajaya this November. Azlinda noted that the creation of the virtual application involved the collaboration of various experts, including those in creative design, medicine, psychology and strategic planning. 'The beauty of our AI counsellor prototype is that it has been developed by experts among local lecturers who can provide guidance shaped by the values of our own society. 'This AI was developed by MOHE through the Department of Higher Education and public universities, with Universiti Teknologi MARA (UiTM) Perak Branch spearheading the mental health AI counsellor prototype project, in collaboration with other local universities such as Universiti Teknologi Malaysia and Universiti Zainal Abidin,' she said.
Straits Times
30-04-2025
- Health
- Straits Times
How Duke-NUS Medical School supports staff to drive healthcare innovations
Professor Patrick Tan in his Duke-NUS lab, where groundbreaking cancer genetics research translates into clinical trials with real-world impact. PHOTO: DUKE-NUS MEDICAL SCHOOL BRANDED CONTENT 'Our role is about service': Why staff stay, grow and drive healthcare innovation at this med school Duke-NUS Medical School's culture of open collaboration and access to a vast clinical ecosystem enables its staff to push boundaries in medicine and public health From installing life-saving devices at Housing Board void decks to discovering new cancer treatments, innovation at Duke-NUS Medical School extends beyond the lab. In March 2025, in collaboration with SingHealth, the school launched its Artificial Intelligence in Medicine Institute (AIMI) with the aim to equip healthcare professionals with the tools and support to develop and apply AI solutions in the real world. There is tremendous use for AI, from finding new drugs to understanding complex biological pathways, to detecting patterns in the emergence of diseases, says Professor Patrick Tan, Duke-NUS' senior vice-dean for research. A Stanford-trained MD (Doctor of Medicine)-PhD holder, the 56-year-old was one of the school's pioneer faculty members and has been appointed the next and fourth dean of the school, effective January 1, 2026. 'The character of Duke-NUS is very special,' he says. 'We're a medical school that produces doctors who do more than clinical care, researchers who do more than publish papers, and administrators who lean into our mission of innovative education and impactful research that transforms the practice of medicine in Singapore and beyond.' This sense of shared purpose is echoed by Associate Professor Shiva Sarraf-Yazdi, who sums it up succinctly: 'Our role is about service.' Duke-NUS was established in 2005 as a partnership between two world-class institutions: Duke University and the National University of Singapore. A former Duke-trained surgeon, she joined Duke-NUS more than a decade ago to focus on medical education. 'The act of surgery itself measures impact in days, weeks or months but education measures impact in decades,' says the 53-year-old, who is now the vice-dean for education overseeing the Duke-NUS MD programme. The school has been ranked as one of Singapore's best employers for five years running, in a list compiled by global research firm Statista in collaboration with The Straits Times. Faculty members and staff have cited a high level of trust, strong emphasis on workplace diversity and clear work expectations as factors that make Duke-NUS stand out as an employer. Prof Tan, who leads a 600-strong research office, says: 'Part of my job is to bring in the best people, assemble the best teams, and make sure they can do their best work with supporting structures in place to tackle the big questions of the future.' The setting up of AIMI marks the school's latest move to leverage cutting-edge technology and interdisciplinary expertise to solve complex healthcare challenges and redefine what's possible in patient care. A spirit of innovation at Duke-NUS Medical School empowers every member to push boundaries, to transform medicine and improve lives. (Seated, from left) Professor Patrick Tan, senior vice-dean for research; professor Thomas Coffman, dean; and Dr Zhou Jin, principal research scientist. (Standing, from left) Mr Anirudh Sharma, director, communications and strategic relations; and associate professor Shiva Sarraf-Yazdi, vice-dean for education. PHOTO: DUKE-NUS MEDICAL SCHOOL Creating real-world impact Prof Tan says the scale and success of the work of Duke-NUS researchers is made possible because of the institution's collaborative model and access to Singapore's broader healthcare ecosystem. That includes his own groundbreaking contributions to stomach cancer research. Prof Tan's work in gastric cancer won the American Association for Cancer Research Team Science Award in 2018 – a first for a team from Asia. Supported by Duke-NUS, his team – comprising researchers from the National Cancer Centre Singapore, the Genome Institute of Singapore and collaborators from Japan, Taiwan and Thailand – identified key genetic abnormalities in stomach cancers and translated those findings into targeted clinical trials. Reflecting on his focus on research rather than clinical care, he says: 'When you provide clinical care, it is to one patient at a time. This is tremendously important. But if you can find the cause of disease and therapy to intervene, there is a much broader level of impact.' Another real-world example is the installation of AEDs (Automated External Defibrillators) across Singapore, an initiative led by Duke-NUS' research on out-of-hospital cardiac arrest survival rates. 'It wasn't a drug, but it saved lives. That's the impact,' says Prof Tan. Breakthroughs in medical research and healthcare Fighting cancer From developing Singapore's first home-grown cancer drug (ETC-159) to mapping stomach tumours for personalised therapies, scientists at Duke-NUS are leading advances in cancer treatment. From developing Singapore's first home-grown cancer drug (ETC-159) to mapping stomach tumours for personalised therapies, scientists at Duke-NUS are leading advances in cancer treatment. Pioneering Covid-19 response Duke-NUS is among the first globally to isolate, culture and characterise the SARS-CoV-2 virus, driving innovations in Covid-19 testing, vaccines and therapeutics – including the world's first FDA-approved neutralising antibody test kit. Duke-NUS is among the first globally to isolate, culture and characterise the SARS-CoV-2 virus, driving innovations in Covid-19 testing, vaccines and therapeutics – including the world's first FDA-approved neutralising antibody test kit. Hope for Parkinson's Duke-NUS is advancing cell therapies for brain diseases like Parkinson's, taking these treatments from the lab to clinical trials in Singapore and overseas. Duke-NUS is advancing cell therapies for brain diseases like Parkinson's, taking these treatments from the lab to clinical trials in Singapore and overseas. Driving longevity research Researchers at Duke-NUS discovered how the IL-11 protein is linked to ageing and excess scar tissue build-ups in organs or tissues, paving the way for new treatments. Researchers at Duke-NUS discovered how the IL-11 protein is linked to ageing and excess scar tissue build-ups in organs or tissues, paving the way for new treatments. Beating cardiac arrest Research led to the placement of over 10,000 automated external defibrillators across Singapore and cardiopulmonary resuscitation training for more than 180,000 people annually – dramatically improving survival from cardiac arrests outside hospitals. Empowering bold innovations Prof Sarraf-Yazdi feels the school's innovation-friendly culture encourages bold ideas. This support has enabled her team to embark on new projects that continually enhance the school's education programme to better prepare students for clinical practice. One of her earlier initiatives was the MD Programme Longitudinal Integrated Clerkship. It was run as a pilot to expose students to multiple clinical disciplines in a holistic approach while enabling them to form stronger connections with patients, mentors and peers. Insights from the pilot helped reshape the MD curriculum, such as the longitudinal C.A.R.E. (Connect, Assimilate, Reflect, Explore) Programme, which now spans the entire curriculum. The programme complements students' capabilities for practice by progressively incorporating essential skills like communication, clinical reasoning, ethics and professionalism, while exploring emerging healthcare priority areas such as Population Health and AI in medicine. Associate Professor Shiva Sarraf-Yazdi with Duke-NUS students during one of their clinical education programmes, practising procedural skills in a safe environment. PHOTO: DUKE-NUS MEDICAL SCHOOL 'It is easy to take bold steps when you are backed by a courageous team and supported by institutional leadership that tolerates failure, embraces change and encourages innovation,' she says. In addition to Duke-NUS, she credits the school's extended ecosystem – including over 2,000 clinical faculty across the SingHealth Duke-NUS Academic Medical Centre – for guiding students through their clinical education. Enduring impact on public health At Duke-NUS, professional growth is not limited to students. By providing a supportive environment including flexible work arrangements to encourage lifelong learning, faculty and staff are enabled to deepen their expertise and expand their capabilities. Prof Sarraf-Yazdi herself pursued two additional degrees while working – a Master of Health Professions Education from Johns Hopkins University and a Master of Business Administration from NUS. Programmes such as the Dean's Excellence Awards and Administrative Achievement Awards also help in highlighting staff contributions and fostering peer appreciation. Prof Tan says: 'There is an ethos and culture to Duke-NUS that has sustained me. 'Here, you will find that many of us stay for quite a long time because we're all attracted to this very dynamic place that tackles some of the key and important questions of the future that affect Singapore and the world.' Read more about Singapore's Best Employers 2025. Join ST's WhatsApp Channel and get the latest news and must-reads.
Yahoo
19-03-2025
- Health
- Yahoo
Advancing Artificial Intelligence (AI) in medicine: New AI Institute launched to drive healthcare innovation; MOU inked to reinforce strong governance
The Artificial Intelligence in Medicine Institute (AIMI) will focus on: Cutting edge AI research and integration into different medical specialties. Ensuring safe, responsible AI adoption, emphasising patient safety and data privacy. Promoting AI education for healthcare professionals and the public Collaborating with industry partners to drive commercialisation of AI innovations. A Memorandum of Understanding was inked with the Coalition for Health AI (CHAI) to reinforce the commitment to responsible, safe and ethical application of AI in Singapore's healthcare space. SINGAPORE, March 18, 2025 /PRNewswire/ -- The SingHealth Duke-NUS Academic Medical Centre (AMC) announced the launch of the Artificial Intelligence in Medicine Institute (AIMI) at the opening ceremony of the AI Health World Summit 2025 today. The event was graced by Guest-of-Honour, Mr Tan Kiat How, Senior Minister of State, Ministry of Digital Development and Information. AIMI is set to bring together SingHealth's data science and AI capabilities and Duke-NUS' academic network to drive research, education and commercialisation. Fostering an environment for in-depth research, education and partnerships in AI An increasingly integral and transformative force in healthcare, AI capabilities aid the diagnosis of diseases, guide clinical treatments, and enhance patient experience. As AI continues to gain widespread use and acceptance, it has become essential to create an environment with the resources that supports healthcare professionals in integrating AI into their work. AIMI aims to empower healthcare professionals across medical specialties with the expertise and support they need to create, develop and apply AI-driven solutions. The Institute will bridge the gap between technical expertise and clinical knowledge by fostering an environment that promotes meaningful partnerships with local and global experts in the field, and providing resources and grants to turn innovative ideas into reality. To equip healthcare professionals and the public with AI knowledge, AIMI will introduce AI101, a flagship online training series offering foundational insights into AI's unique considerations and applications in healthcare. While the use of AI has tremendous potential in unlocking benefits for patients and healthcare professionals, it is critical to ensure ethical, responsible and trustworthy applications. Through the development of guidelines, publications and policy recommendations, AIMI aims to promote a strong and robust governance framework as efforts to encourage adoption of AI increase. Associate Professor Liu Nan, Director of the Duke-NUS AI + Medical Sciences Initiative (DAISI) and Co-Director of AIMI, said: "AI has the power to revolutionise healthcare, but its adoption must be responsible and patient-centred. AIMI brings together expertise from healthcare, engineering and data science to transform data into vital intelligence that can be used to make critical care decisions faster at the patients' bedside. Beyond technology, we aim to cultivate future leaders who will drive AI advancements through strategic collaborations and education." Please refer to Annex A for more details on AIMI. MOU signing with CHAI to strengthen ethical AI deployment in healthcare Another highlight of the AI Health World Summit 2025 was the inking of a two-year Memorandum of Understanding (MOU) between SingHealth, Singapore's largest public healthcare cluster, and the Coalition for Health AI (CHAI), a non-profit organisation in the United States of America committed to developing industry best practices and frameworks to further innovation, safety, and security for health AI. This MOU, which marks CHAI's first international collaboration, aims to strengthen Singapore's position as a global hub for healthcare AI and enables the promotion of AI ethics worldwide. Through this partnership, SingHealth and CHAI will jointly develop AI guidelines, white papers, publications and policy recommendations incorporating global best practices and regulatory insights to strengthen governance around AI use in Singapore's healthcare system. In addition, the two organisations will work together to implement educational initiatives aimed at enhancing AI literacy and responsible AI use that will be accessible for clinicians, developers and the public. During the two years of the agreement, SingHealth and CHAI will host at least one Global Summit gathering experts, policymakers, and healthcare leaders from all over the world, to facilitate knowledge exchange and the sharing of best practices to deepen their standing as thought leaders on AI governance and ethics. Associate Professor Daniel Ting, Director, AI Office, SingHealth and Co-Director of AIMI said: "As AI becomes more widely used in healthcare, it is crucial for the tech industry and regulatory bodies to collaborate closely and proactively develop comprehensive guidelines to ensure that AI-driven solutions are compliant and in accordance with stringent safety guidelines and governance frameworks. Our ultimate aim is to create transparent, explainable, and ethical AI systems that empower clinicians to deliver precise and personalised care to every patient, to achieve greater efficiency and positive outcomes in healthcare delivery." Please refer to Annex B for more details on the SingHealth-CHAI MOU. About the AI Health World Summit 2025 Organised biennially by the SingHealth Duke-NUS AMC with A*STAR as co-organiser, the AI Health World Summit serves as a pivotal gathering for global leaders across healthcare, academia, government, legal, and industry sectors to explore the latest advancements and applications of AI in healthcare. The Summit features exciting plenary sessions covering a rich variety of topics including last-mile adoptions of AI technologies, clinical applications in healthcare, data governance frameworks, AI and data privacy safeguards, advancements in vision and language models tailored for health contexts, and explainable and responsible AI practices. Notable speakers include Prof Nigam Shah, Chief Data Scientist, Stanford Health Care, USA; Prof Wong Tien Yin, Founding Head & Senior Vice-Chancellor, Tsinghua University, China; Dr Rupa Sarkar, Editor-in-Chief, The Lancet Digital Health, UK; and Mr Sim Feng-Ji, Deputy Secretary, Digital Government, Ministry of Digital Development and Information (MDDI), Singapore. More information is available here: About SingHealth Duke-NUS Academic Medical Centre The SingHealth Duke-NUS Academic Medical Centre (AMC) draws on the collective strengths of SingHealth and Duke-NUS Medical School to provide our patients and community with the best outcomes and experience. By leveraging the synergies in clinical care, research and education created through our Academic Clinical Programmes, Disease Centres and Joint Institutes, the SingHealth Duke-NUS AMC fosters the exchange of scientific knowledge and clinical perspectives to accelerate innovation and new discoveries, advance the practice of medicine as well as nurture the next generation of healthcare professionals. SingHealth delivers comprehensive, multi-disciplinary and integrated care across a network of acute hospitals, national specialty centres, polyclinics and community hospitals. Offering over 40 clinical specialties, SingHealth is Singapore's largest public healthcare cluster. Duke-NUS Medical School, Singapore's flagship graduate entry medical school, nurtures multifaceted 'Clinician Plus' graduates to become leaders in the global healthcare and biomedical ecosystem, while scientists from its five Signature Research Programmes and 10 Centres transform medicine and improve lives with groundbreaking scientific discoveries and translational innovations. For more information, please visit: Annex A About the SingHealth Duke-NUS Artificial Intelligence in Medicine Institute (AIMI) The SingHealth Duke-NUS Artificial Intelligence in Medicine Institute (AIMI) is a Joint Institute between SingHealth and Duke-NUS Medical School. AIMI brings together data science and AI capabilities from the hospital system and the university system, providing world class clinicians and AI scientists ease of access to each other's expertise. The institute also aims to facilitate collaboration, research and development in AI for healthcare locally and globally. Focus Areas of AIMI: Promote bench-to-bedside AI research that meets evolving healthcare needs AIMI aims to advance research by developing cutting edge research in AI in healthcare, providing access to resources, grants and local and global expertise in the field, catalysing the development of tools that meet the specific care needs of patients and the community in Singapore. Promote safe and responsible AI in the healthcare community Through the development of AI guidelines, publications and policy recommendations, AIMI aims to drive efforts in AI governance to regulate the use of AI in the healthcare community and advocate for ethical treatment of healthcare data that puts patient safety and data privacy at the forefront. Support local and global commercialisation of AI Health innovations AIMI aims to support the commercialization and licensing of AI innovations and spin-off of AI-driven startups, through partners in the AMC and ecosystem, and fostering collaborations with local and global industry partners, establishing Singapore as a leader in AI healthcare innovation on the world map. Nurture the future pipeline of healthcare professionals Through comprehensive training programmes, mentorships, and conferences, AIMI aims to promote the education of healthcare professionals and the public on AI applications in health, to grow the next generation of forward-looking, AI-literate healthcare professionals. Annex B About the Memorandum of Understanding (MOU) between SingHealth and the Coalition for Health AI (CHAI) Overview SingHealth and the Coalition for Health AI (CHAI) have entered a two-year Memorandum of Understanding (MOU) to advance responsible AI in healthcare. This collaboration, which is CHAI's first international collaboration, will strengthen Singapore's position as a global hub for AI in healthcare while promoting ethical AI deployment worldwide. About CHAI CHAI is a non-profit organisation in the United States of America dedicated to establishing guidelines and best practices for the responsible use of AI in healthcare. Founded in 2021 by clinicians and data scientists, CHAI aims to ensure that AI technologies are safe, effective, and equitable. The MOU outlines three primary areas of cooperation: Singapore as a Global AI Hub: Global Summit SingHealth will co-host with CHAI a Global Summit in Singapore within the next two years, cementing the nation's status as a leading AI hub. This landmark event will attract global experts, policymakers, and healthcare leaders to Singapore, driving discussions on AI governance, ethics, and implementation. It will showcase Singapore's advanced healthcare infrastructure and AI capabilities on the world stage. AI in Health Workgroups and Guideline Development SingHealth and CHAI will collaborate to develop AI guidelines, white papers, publications, and policy recommendations. This partnership will enable Singapore to play a pivotal role in shaping global AI standards in healthcare, leveraging its unique position as a technologically advanced city-state with a robust healthcare system. The resulting publications will incorporate Singapore's innovative practices alongside global insights, potentially influencing AI regulations worldwide. Raising Awareness of Trustworthy and Responsible AI in Healthcare The collaboration will focus on raising awareness of trustworthy and responsible AI in healthcare within Singapore. Joint initiatives will educate local clinicians, developers, and policymakers on AI ethics, enhancing Singapore's AI literacy across the healthcare ecosystem. By developing tailored educational materials and workshops, this partnership aims to nurture a new generation of AI-savvy healthcare professionals in Singapore. View original content to download multimedia: SOURCE SingHealth
